Amgen To Present At The 2021 Annual Cowen IO Summit

Rhea-AI Summary

Amgen will present at the 2021 Cowen IO Summit on November 15 at 2:15 p.m. ET. Dr. David M. Reese, Executive VP of Research and Development, will lead the presentation. The event will be accessible via live audio webcast for media, investors, and the public on Amgen's website. An archived version will be available for 90 days post-event. Amgen is recognized for its innovative biotechnological approaches to serious illnesses, leveraging human genetics to enhance health outcomes for millions globally.

THOUSAND OAKS, Calif., Nov. 10, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 annual Cowen IO Summit at 2:15 p.m. ET on Monday, Nov. 15, 2021. David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media)
Arvind Sood, 805-447-1060 (investors)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-2021-annual-cowen-io-summit-301421615.html

SOURCE Amgen

FAQ

What time is Amgen's presentation at the Cowen IO Summit on November 15, 2021?

Amgen's presentation at the Cowen IO Summit is scheduled for 2:15 p.m. ET on November 15, 2021.

Who will represent Amgen at the 2021 Cowen IO Summit?

Dr. David M. Reese, Executive Vice President of Research and Development, will represent Amgen at the summit.

How can I access Amgen's presentation at the Cowen IO Summit?

You can access Amgen's presentation via live audio webcast on their website during the event.

Will the Amgen presentation at the Cowen IO Summit be available later?

Yes, the presentation will be archived and available for replay for at least 90 days after the event.

What is Amgen's focus in the biotechnology sector?

Amgen focuses on discovering and developing innovative human therapeutics for serious illnesses, using advanced human genetics.